OBITUARY- Riccardo Saccardi (20th April 1956–19th February 2024)-Reference-Cited by-同舟云学术

OBITUARY- Riccardo Saccardi (20th April 1956–19th February 2024)

Published:2024-05-01 Issue:8 Volume:59 Page:1202-1203
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Bacigalupo Andrea^ORCID,Bonifazi Francesca^ORCID,Ciceri Fabio^ORCID,Gluckman Eliane,Greco Raffaella^ORCID,Nozzoli Chiara,Lombardini Letizia,Martino Massimo^ORCID,Rambaldi Alessandro^ORCID,Rocha Vanderson,Ruggeri Annalisa^ORCID,Snowden John^ORCID,Sureda Anna^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41409-024-02296-1.pdf

Reference4 articles.

1. Saccardi R, Putter H, Eikema DJ, Busto MP, McGrath E, Middelkoop B, et al. Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT): an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE). Bone Marrow Transpl. 2023;58:659–66. https://doi.org/10.1038/s41409-023-01924-6.

2. Capello E, Saccardi R, Murialdo A, Gualandi F, Pagliai F, Bacigalupo A, et al. Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis. Neurol Sci. 2005;26:S200–3. https://doi.org/10.1007/s10072-005-0514-6.

3. Muraro PA, Pasquini M, Atkins HL, Bowen JD, Farge D, Fassas A, et al. Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis. JAMA Neurol. 2017;74:459–69. https://doi.org/10.1001/jamaneurol.2016.5867.

4. Mancardi GL, Sormani MP, Gualandi F, Saiz A, Carreras E, Merelli E, et al. Autologous hematopoietic stem cell transplantation in multiple sclerosis: a phase II trial. Neurology. 2015;84:981–8. https://doi.org/10.1212/WNL.0000000000001329.